Genomic Health, Inc. (GHDX) Tops Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Financial Fact:
Income (loss) from operations: -16.92M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Income (loss) from operations: -16.92M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Genomic Health, Inc. (NASDAQ: GHDX) reported Q1 EPS of $0.02, $0.05 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $58.58 million versus the consensus estimate of $56.27 million.
For earnings history and earnings-related data on Genomic Health, Inc. (GHDX) click here.
For earnings history and earnings-related data on Genomic Health, Inc. (GHDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
- 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
